Grant: Master's Award: Canada Graduate Scholarships
McMaster University
$17,500.00
The Effect of a Multi-ingredient Antioxidant supplement on Leber's Hereditary Optic Neuropathy Mesenchymal Stem Cells
EF 2022-23
Résumé
Leber's Hereditary Optic Neuropathy (LHON) is an inherited mitochondrial DNA disorder that has well-characterized mutations, resulting in centro-cecal visual loss. There are three prevalent genotypic presentations of LHON that can exist with varied mitochondrial dysfunction. These mutations impact complex I subunits, leading to decreased energy flux through the electron transport chain (ETC) and increased reactive oxygen species (ROS) production. A mechanistic understanding of the ETC would suggest that providing natural coenzyme Q10 with other antioxidants would address both complex I failure and generated ROS-associated damage. This has not yet been explored experimentally in an in-vitro model of complex I-associated disease. This research project would determine baseline differences in complex I function, ROS production and cell viability between affected LHON and age- and sex-matched control mesenchymal stem cell lines. We will also examine the effects of a combinatorial antioxidant supplement on mitochondrial respiration and ROS production. Mitochondrial function will be characterized by outcomes of mitochondrial function (oxygen consumption rate measured via Seahorse XF extracellular flux), immunocytochemistry and immunohistochemistry for ROS production. There is no effective treatment for LHON and other mitochondrial diseases with similar complex I impairments. Understanding the redox pathways by which a multi-ingredient antioxidant supplement will work provides critical evidence to understanding the effectiveness of antioxidants on mitochondrial function. Our study will uncover mechanistic differences in mitochondrial function amongst the common mutations within LHON and will enhance our understanding of other mitochondrial diseases with similar pathologies.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
486578
Name
Chiarot Alessandra
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The Effect of a Multi-ingredient Antioxidant supplement on Leber's Hereditary Optic Neuropathy Mesenchymal Stem Cells
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antioxidant; Complex I; Idebenone; Leber'S Hereditary Optic Neuropathy; Mitochondrial Disease; Mitochondrial Dysfunction; Mitochondrial Respiration; Oxidative Phosphorylation; Reactive Oxygen Species; Ubiquinone
Abstract
Leber's Hereditary Optic Neuropathy (LHON) is an inherited mitochondrial DNA disorder that has well-characterized mutations, resulting in centro-cecal visual loss. There are three prevalent genotypic presentations of LHON that can exist with varied mitochondrial dysfunction. These mutations impact complex I subunits, leading to decreased energy flux through the electron transport chain (ETC) and increased reactive oxygen species (ROS) production. A mechanistic understanding of the ETC would suggest that providing natural coenzyme Q10 with other antioxidants would address both complex I failure and generated ROS-associated damage. This has not yet been explored experimentally in an in-vitro model of complex I-associated disease. This research project would determine baseline differences in complex I function, ROS production and cell viability between affected LHON and age- and sex-matched control mesenchymal stem cell lines. We will also examine the effects of a combinatorial antioxidant supplement on mitochondrial respiration and ROS production. Mitochondrial function will be characterized by outcomes of mitochondrial function (oxygen consumption rate measured via Seahorse XF extracellular flux), immunocytochemistry and immunohistochemistry for ROS production. There is no effective treatment for LHON and other mitochondrial diseases with similar complex I impairments. Understanding the redox pathways by which a multi-ingredient antioxidant supplement will work provides critical evidence to understanding the effectiveness of antioxidants on mitochondrial function. Our study will uncover mechanistic differences in mitochondrial function amongst the common mutations within LHON and will enhance our understanding of other mitochondrial diseases with similar pathologies.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chiarot, Alessandra
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~